MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Does Sarepta Therapeutics' Director Share Sale Signal to Investors

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does Director Mitchell Tyson's Substantial Share Sale Mean for Photronics Investors

2 months ago

What Does Director Edman's Recent Sale Mean for TTMI Investors

2 months ago

What Does a Director's Sale of HURN Shares Really Mean

2 months ago

What Does a CAO's Share Sale and Resignation Signal for Enhabit (EHAB) Investors

3 months ago

CareDx's CEO Sells 17K Shares

CareDx CEO John Hanna sold 17,683 shares (~$425K) at ~$24.03 each on June 15, representing 2.7% of his direct holdings.

CDNA

Stock News•1 week ago

What Does an Opendoor Director's Sale of 40,000 Company Shares Mean for Investors?

An Opendoor director sold 40,000 company shares in a recent insider transaction, signaling potential caution from leadership.

OPEN

Stock News•3 weeks ago

Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report?

Sarepta Therapeutics (SRPT) fell 19.9% since its last earnings report 30 days ago, as investors weighed results and the outlook for its gene therapy franchise.

SRPT

Stock News•3 weeks ago

Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors.

Enliven Therapeutics CMO sold 5,000 shares of company stock, following a period of strong one-year gains for the oncology-focused biotech. The sale represents a divestment by a key executive during th...

ELVN